The National Registry Study for the Real-world Patients with Parkinsonian Disorders in China
Launched by HUASHAN HOSPITAL · Aug 26, 2018
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The National Registry Study for Real-world Patients with Parkinsonian Disorders in China aims to gather important information about individuals living with Parkinsonian Disorders. This study will help researchers understand how these conditions affect daily life and overall health. If you or someone you know has been diagnosed with a Parkinsonian Disorder, you may be eligible to participate. The study welcomes anyone with these conditions, and you'll be asked to sign a consent form before joining.
Once you’re part of the study, you will provide information through online questionnaires about your health, family history, mood, sleep, diet, exercise, and memory. You'll also complete various assessments to measure your quality of life and other important factors. Participants are encouraged to return every three months to update their information and take part in follow-up assessments. This study is a great opportunity to contribute to our understanding of Parkinsonian Disorders and improve care for patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Anyone with Parkinsonian Disorders is welcome to join the Registry.
- Exclusion Criteria:
About Huashan Hospital
Huashan Hospital, affiliated with Fudan University in Shanghai, is a leading medical institution renowned for its commitment to innovative research and high-quality patient care. As a prominent clinical trial sponsor, Huashan Hospital leverages its extensive expertise in various medical disciplines to advance the development of new therapies and treatment modalities. The hospital's state-of-the-art facilities and multidisciplinary teams facilitate rigorous clinical investigations, ensuring adherence to ethical standards and regulatory compliance. With a focus on improving patient outcomes, Huashan Hospital actively collaborates with academic and industry partners to drive forward-thinking research initiatives that address critical healthcare challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Shanghai, Shanghai, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials